Big news: DEA has finally acted on SRI's application to manufacture cannabis for use in clinical trials! As I've explained in previous posts, Matt Zorn and I have been representing SRI and Dr. Sue Sisley in a D.C. Circuit case against DEA and the Attorney General seeking a writ of mandamus ordering the government to take action on SRI's application to manufacture cannabis for use in clinical trials. After years of unexplained delays, DEA finally took action just two days before its response to SRI's mandamus petition was due in the D.C. Circuit!
And because DEA has announced that it intends to process all of the applications it has received--not just SRI's--this is a huge victory not just for Dr. Sisley and SRI but for all of the other applicants whose bids to manufacture have been stuck in the same regulatory limbo for years. I'll have much more to say about this later today, but was eager to break the good news! I'll end with this unbelievable snippet from the notice that DEA released this morning: